Survival advantage from imatinib compared with the combination interferon- plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials (Q58179557)
Jump to navigation
Jump to search
scientific article published on 20 April 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Survival advantage from imatinib compared with the combination interferon- plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials |
scientific article published on 20 April 2006 |
Statements
Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials (English)
Lydia Roy
Joëlle Guilhot
Tillmann Krahnke
Agnès Guerci-Bresler
Steve O'Brien
Charlene So
Giorgio Massimini
François Guilhot
20 April 2006